Have You Been Diagnosed with Cancer After Taking Zantac?

OBTAIN A FREE ZANTAC CASE EVALUATION BY ONE OF OUR ZANTAC ATTORNEYS BY COMPLETING THE FORM BELOW







    Zantac Lawyers

    OUR ZANTAC LAWYERS ARE CURRENTLY REVIEWING CLAIMS OF INDIVIDUALS WHO TOOK ZANTAC (RANITIDINE) AND WERE LATER DIAGNOSED WITH CANCER

    If you’ve used Zantac or generic brands of ranitidine in the past, it’s important to know about the possible dangers of this over-the-counter drug. You may have heard in the news that Zantac (ranitidine) has been linked to cancer. Nationwide, lawsuits against Zantac manufacturers allege the drug contains a cancer-causing chemical called N-nitrosodimethylamine (NDMA). At Marin and Barrett, Inc., our Zantac attorneys are currently reviewing claims of individuals who took Zantac and were later diagnosed with cancer.

    Recent, hundreds of cases have been filed involving former Zantac users who have been diagnosed with cancer following years of exposure to ranitidine. The Zantac lawyers who have filed the existing federal Zantac lawsuits allege the defendants, including Boehringer Ingelheim Pharmaceuticals, Sanofi, Chattem, Pfizer, and Glaxosmithkline, failed to disclose to consumers that the weight of scientific evidence showed Zantac exposed users to unsafe levels of NDMA and that they failed to report these risks to the FDA. These federal Zantac lawsuits have been consolidated for purposes of discovery and other pre-trial aspects of the lawsuits in the U.S. District Court for the Southern District of Florida and are overseen by U.S. District Judge Robin L. Rosenberg.

    ZANTAC, RANITIDINE AND CANCER

    Approved by the United States Food and Drug Administration (FDA) in 1981, Zantac (ranitidine) was long considered to be a safe and effective treatment of gastro-esophageal reflux disease (GERD). In fact, the active ingredient in Zantac, ranitidine, has been used by hundreds of millions of people with heartburn, acid reflux, and gastric ulcer symptoms. It is estimated that over 120 million over-the-counter packages of Zantac have been sold annually in the United States alone.

    However, recent studies have shown that persons taking Zantac or ranitidine are at a heightened risk of developing cancer. As a result, on April 1, 2020, the FDA released a statement requesting that manufacturers withdraw all prescription and over-the-counter (OTC) Zantac and ranitidine drugs from the market immediately.

    On April 1st, 2020, the FDA requested all Zantac (ranitidine) products be pulled from the market immediately. The recall includes all prescription and over-the-counter ranitidine drugs as ongoing investigations uncovered levels of N-Nitrosodimethylamine (NDMA), a probable human carcinogen, increase over time.

     

    If you or a loved one have been diagnosed with cancer after using Zantac
    or ranitidine, call the Zantac Attorneys at Marin and Barrett, Inc. today at
    (888) 348-2735 for a free, no obligation consultation. We can help with
    your Zantac lawsuit. You can also fill out our one-minute questionnaire
    below to find out if you have a claim.